Group 1 - Guangdong Mingzhu expects a net profit increase of 2908.49%-3577.04% year-on-year for 2025 [1] - Sainuo Medical anticipates a net profit growth of 2767%-3233% year-on-year for 2025 [1] - Lingdian Electric Control forecasts a net profit rise of 640.16%-804.64% year-on-year for 2025 [1] - Bojie Co. predicts a net profit increase of 484.16%-618.97% year-on-year for 2025 [1] - Kexing Pharmaceutical expects a net profit growth of 328.83%-455.89% year-on-year for 2025 [1] - Xiangcai Co. anticipates a net profit increase of 266.41%-403.81% year-on-year for 2025 [1] - Xinyi Sheng forecasts a net profit rise of 231.24%-248.86% year-on-year for 2025 [1] - Tongzhou Electronics predicts a net profit increase of 151.40%-230.42% year-on-year for 2025 [1] - Zhaofeng Co. expects a net profit growth of 136.26%-164.89% year-on-year for 2025 [1] - Kaige Precision Machinery anticipates a net profit increase of 133.99%-193.55% year-on-year for 2025 [1] - Sankeshu forecasts a net profit rise of 128.96%-189.21% year-on-year for 2025 [1] - Huazi Industrial expects a net profit growth of 128.00%-167.00% year-on-year for 2025 [1] - Zhite New Materials anticipates a net profit increase of 117.11%-171.39% year-on-year for 2025 [1] - Ecovacs expects a net profit growth of 110.90%-123.30% year-on-year for 2025 [1] - Jingquan Hua forecasts a net profit increase of 109.32%-140.72% year-on-year for 2025 [1] - Guoxuan High-Tech anticipates a net profit rise of 107.16%-148.59% year-on-year for 2025 [1] - Changjiang Securities expects a net profit growth of 101.37% year-on-year for 2025 [1] - Shanwaishan forecasts a net profit increase of 98%-125% year-on-year for 2025 [1] - Zhongji Xuchuang anticipates a net profit rise of 89.50%-128.17% year-on-year for 2025 [1] - Huachuang Yuxin expects a net profit growth of 86%-175% year-on-year for 2025 [1] - Kori Technology forecasts a net profit increase of 68.61%-115.25% year-on-year for 2025 [1] - Western Gold anticipates a net profit rise of 67.58%-93.21% year-on-year for 2025 [1] - Shandong Gold expects a net profit growth of 56%-66% year-on-year for 2025 [1] - Huaxi Biological anticipates a net profit increase of 54.93%-83.63% year-on-year for 2025 [1] - Nairui Radar expects a net profit growth of approximately 54.16% year-on-year for 2025 [1] - Lingyun Optical anticipates a net profit rise of approximately 50.75% year-on-year for 2025 [1] - Zhongjin Company expects a net profit increase of 50%-85% year-on-year for 2025 [1] - Dongwu Securities forecasts a net profit growth of 45%-55% year-on-year for 2025 [1] - Longping High-Tech anticipates a net profit increase of 14.17%-66.86% year-on-year for 2025 [1] Group 2 - Jiangfeng Electronics expects a net profit increase of 7.5%-27.5% year-on-year for 2025 [2]

Macroeconomic Dynamics - The Ministry of Finance announced that the securities transaction stamp duty is expected to reach 203.5 billion yuan in 2025, representing a growth of 57.8% [1] Energy Sector - The National Development and Reform Commission and the National Energy Administration will increase the proportion of fixed costs recovered through capacity pricing for coal-fired power plants to no less than 50% [2] Telecommunications Industry - According to the China Academy of Information and Communications Technology, the domestic smartphone shipment in December 2025 is projected to be 24.473 million units, a year-on-year decline of 29.1%. For the entire year of 2025, the total smartphone shipment is expected to be 307 million units, down 2.4% year-on-year [3] Financial Institutions - China International Capital Corporation (CICC) expects its net profit attributable to shareholders to be between 8.542 billion yuan and 10.535 billion yuan in 2025, reflecting a year-on-year increase of 50% to 85% [9] Market Data - The A-share market showed mixed results on January 30, with the Shanghai Composite Index down 0.96% and the ChiNext Index up 1.27%. The total trading volume was approximately 283.55 billion yuan, a decrease of about 39.44 billion yuan from the previous trading day [10] Company Dynamics - Sino Medical announced an expected revenue of 519 million to 526 million yuan for 2025, with a year-on-year growth of 13% to 15%. The net profit attributable to shareholders is projected to be between 43 million and 50 million yuan, indicating a significant year-on-year increase of 2767% to 3233% [13]

★ 宏观动态 ★ 财政部：2025年证券交易印花税增长57.8% 1月30日，财政部举行新闻发布会，介绍2025年财政收支情况。会上，财政部国库司副司长郑涌介绍，2025 年，证券交易印花税达到2035亿元，增长57.8%。 两部门：将通过容量电价回收煤电机组固定成本的比例提升至不低于50% 国家发展改革委、国家能源局发布关于完善发电侧容量电价机制的通知。其中提出，完善煤电及天然气发电容 量电价机制。各地按照《关于建立煤电容量电价机制的通知》（发改价格〔2023〕1501号）要求，将通过容量 电价回收煤电机组固定成本的比例提升至不低于50%，可结合当地市场建设、煤电利用小时数等实际情况进一 步提高。省级价格主管部门可对天然气发电建立容量电价机制，容量电价按照回收天然气发电机组一定比例固 定成本的方式确定。 中国信通院：2025年12月国内市场手机出货量2447.3万部，同比下降29.1% 据中国信通院，2025年12月，国内市场手机出货量2447.3万部，同比下降29.1%，其中，5G手机2213.2万部， 同比下降27.3%，占同期手机出货量的90.4%。2025年1-12月，国内市场手机出货量3.07亿部 ...

证券日报网讯 1月30日，赛诺医疗在互动平台回答投资者提问时表示，公司近年在欧洲陆续开展了冠脉 药物洗脱支架相关的系列临床研究，在产品品质方面树立了良好的口碑。在商业化方面，公司主要通过 与欧盟境内经销商合作的方式开展出口业务，业务收入在公司整体营业收入中占比尚不是很高。随着未 来更多产品获得CE认证，以及业务渠道的加强，公司有望不断提高该区域的业务收入。 （编辑 楚丽君） ...

赛诺医疗表示，由于营业收入同比预计增长13%至15%，营业成本和管理费用预计同比均小幅增长，以 及销售费用、研发费用及资产减值损失预计同比下降，加之上年同期归属净利润基数较小等多方面因素 共同影响，公司预计本期归属净利润将实现大幅增长。 北京商报讯（记者 丁宁）1月30日晚间，赛诺医疗（688108）发布2025年度业绩预增公告显示，预计 2025年实现归属净利润为4300万元至5000万元，同比增长2767%至3233%。 ...

智通财经APP讯，赛诺医疗(688108.SH)发布公告，公司预计2025年度实现归属于上市公司股东的净利 润为4300万元至5000万元，较上年同期增加4,150万元至4,850万元，同比增长2767%至3233%。 ...

格隆汇1月30日丨赛诺医疗(688108.SH)公布2025年度业绩预增公告，报告期内，预计实现归属于上市公 司股东的净利润与上年同期相比将大幅增长：预计实现归属于上市公司股东的净利润为4,300万元至 5,000万元，较上年同期增加4,150万元至4,850万元，同比增长2,767%至3,233%。报告期内，预计实现归 属于上市公司股东的扣除非经常性损益后的净利润实现扭亏为盈：预计实现归属于上市公司股东的扣除 非经常性损益后的净利润为3,000万元至3,580万元，较上年同期增加4,752万元至5,332万元，同比增长 271%至304%。 报告期内，公司球囊和支架产品的销量同比大幅增长，产品的规模效应进一步显现，从而带动单位产品 成本同比大幅下降；然而单位成本下降对营业成本的节约效应略小于销量增长带来的成本增加影响，因 此预计营业成本同比小幅增长。 ...

每经AI快讯，赛诺医疗1月30日晚间发布业绩预告，报告期内，预计实现归属于上市公司股东的净利润 与上年同期相比将大幅增长：预计实现归属于上市公司股东的净利润为4300万元~5000万元，较上年同 期增加4150万元~4850万元，同比增长2767%~3233%。 （记者 王晓波） 每经头条（nbdtoutiao）——核电建设热潮下，设备厂忙到"飞起"！订单已排至2028年，员工三班倒， 产线24小时不停 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每日经济新闻 ...

每经AI快讯，1月30日，赛诺医疗(688108.SH)公告称，预计2025年归属于上市公司股东的净利润为4300 万元至5000万元，较上年同期增加4150万元至4850万元，同比增长2767%至3233%。业绩增长主要因冠 脉及神经介入业务收入增长、营业成本和管理费用小幅增长、销售费用及研发费用下降、资产减值损失 大幅减少，叠加上年同期净利润基数较小。 ...

赛诺医疗公告称，2025年预计营收5.19亿元至5.26亿元，同比增长13%至15%；预计归属于上市公司股 东的净利润4300万元至5000万元，同比增长2767%至3233%；扣非净利润3000万元至3580万元，实现扭 亏为盈。营收增长主因冠脉介入业务和神经介入业务收入增加；净利润大幅增长受营收增长、成本费用 变动及上年基数小等因素影响。 ...